Difficulty: Medium
Average Score: 68%
Practice
The following statements are correct EXCEPT:
Correct answer
B
Rationale
In the context of cardiovascular drug therapy, the correct answer to the question is option B) LMWH is eliminated solely by renal excretion. This statement is incorrect because LMWH (Low Molecular Weight Heparin) is not solely eliminated by renal excretion. While a significant portion of LMWH is indeed eliminated renally, a considerable amount is also metabolized in the liver. This differentiation is crucial in clinical practice as patients with compromised liver function may require dose adjustments for LMWH therapy.
Regarding the other options:
A) Thrombocytopenia is more commonly associated with unfractionated heparin than LMWH: This statement is true as unfractionated heparin has a higher incidence of causing immune-mediated thrombocytopenia compared to LMWH.
C) Neither heparin nor LMWH cross the placenta: Both heparin and LMWH are large molecules that do not cross the placental barrier easily, thus making them preferred anticoagulants in pregnant women due to their lower risk of fetal exposure.
D) Fondaparinux selectively binds and inhibits factor Xa: This statement is correct as fondaparinux is a synthetic pentasaccharide that specifically binds to antithrombin III, leading to selective inhibition of factor Xa.
Understanding the differences in pharmacokinetics, mechanisms of action, and clinical considerations of cardiovascular drugs is essential for healthcare professionals managing patients on these therapies. It is crucial to have a clear understanding of drug characteristics to ensure safe and effective treatment outcomes in cardiovascular patients.
Regarding the other options:
A) Thrombocytopenia is more commonly associated with unfractionated heparin than LMWH: This statement is true as unfractionated heparin has a higher incidence of causing immune-mediated thrombocytopenia compared to LMWH.
C) Neither heparin nor LMWH cross the placenta: Both heparin and LMWH are large molecules that do not cross the placental barrier easily, thus making them preferred anticoagulants in pregnant women due to their lower risk of fetal exposure.
D) Fondaparinux selectively binds and inhibits factor Xa: This statement is correct as fondaparinux is a synthetic pentasaccharide that specifically binds to antithrombin III, leading to selective inhibition of factor Xa.
Understanding the differences in pharmacokinetics, mechanisms of action, and clinical considerations of cardiovascular drugs is essential for healthcare professionals managing patients on these therapies. It is crucial to have a clear understanding of drug characteristics to ensure safe and effective treatment outcomes in cardiovascular patients.